Annals of Clinical Microbiology and Antimicrobials · 2017 · 24 citations · 20 references
Veterinary MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyImmunology Of Infectious DiseasesMedical MicrobiologyAntigen Detection AssaysBacterial InfectionsDiagnostic BacteriologyPathogen DetectionSerological DiagnosisSerological DiagnosticsBrucella SpeciesDiagnostic Marker DiscoveryImmunoassay Cross-reactivityIndirect Enzyme-linked Immunosorbent AssayInfectious Disease SerologyPathogen Antigen DetectionSerological AntigensSerological Identification
BACKGROUND: The numerous drawbacks of current serological tests for diagnosis of brucellosis which mainly results from cross reactivity with LPS from other gram-negative bacteria have generated an increasing interest to find more specific non-LPS antigens. Previous studies had indicated that Brucella VirB12 protein, a cell surface protein and component of type IV secretion system, induces antibody response during animal infection. However, this protein has not yet been tested as a serological diagnostic marker in human brucellosis. METHODS: Recombinant VirB12 protein was prepared and evaluated the efficacy of it in an indirect enzyme-linked immunosorbent assay (ELISA) for brucellosis with sera collected from different region of Iran and the results were compared with a commercial ELISA kit. RESULTS: Sera from human brucellosis patients strongly reacted to the purified recombinant VirB12. The sensitivity, specificity, accuracy, negative predictive value and positive predictive value of recombinant VirB12-based ELISA related to the commercial-ELISA method were 87.8, 94, 90, 80 and 96.6% respectively. CONCLUSIONS: We concluded that antigenic VirB12 have a property value that can be considered as a candidate for using in serodiagnostic tests for human brucellosis.
20
Melissa M. Kahl-McDonagh, Thomas A. Ficht · Infection and Immunity · 2006 · 83 citations · Full text